Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Work-from-home guidance and face masks can be back in winter in UK

Mon, 13th Sep 2021 11:19

(Alliance News) - Guidance to work from home and the mandatory use of face masks are likely to be retained as options in the Covid winter plan due to be set out by UK Prime Minister Boris Johnson.

The prime minister will tell the nation on Tuesday how the country can learn to live with the virus, underlining how vaccinations will be a central part of the response to coronavirus in the coming months.

Covid laws that are no longer required will be ditched and plans for vaccine passports for nightclubs and other large crowd venues have been shelved.

The travel traffic lights system is also expected to be scrapped and PCR tests will no longer be required for fully vaccinated travellers.

Speaking on Monday, Work & Pensions Secretary Therese Coffey said some regulations may still be needed as the NHS prepares to battle both Covid and seasonal flu in the winter months.

Asked about maintaining the work-from-home advice, she told BBC Breakfast of the need to keep some rules on the table, adding: "Whether that's with what you just mentioned or making sure statutory sick pay can be paid from day one rather than day four, as tends to happen in more regular times.

"These are the sensible measures I think that we're going to keep."

On the issue of masks, she added: "The prime minister will be setting out the Covid winter plan tomorrow. I think my approach, and I see that with a lot of employers' organisations, is about having a situation-specific approach."

It comes after Health Secretary Sajid Javid said on Sunday that vaccine passports were a "huge intrusion into people's lives" and there were no current plans to go ahead with them.

He said: "You have got to be really, really certain that's what you want to do. We have looked at it and whilst we will keep it in reserve I am pleased to say that we will not be going ahead."

However, Coffey said the introduction of vaccine passports had not been "ruled out forever".

She said: "As Sajid Javid set out yesterday, although the formal decision is still to be made, but having reflected and looked at the details of the proposal that it's not deemed necessary at this moment in time.

"But they haven't been ruled out forever. It's reflecting the fact that a lot of young people have come forward and got their vaccinations over the summer."

The government has yet to set out the plans for booster vaccinations, which are expected to be given to the most vulnerable people first.

A decision has also not yet been made by the UK's chief medical officers on extending the Covid vaccination programme to healthy 12 to 15-year-olds.

The Joint Committee on Vaccination & Immunisation has already said the margin of benefit is considered too small to support universal vaccination of healthy youngsters at this time.

Elsewhere, Neil Ferguson, whose modelling was instrumental to the UK going into lockdown in March 2020, has said he is in favour of a booster programme.

The scientist, from Imperial College London, and a member of the Scientific Advisory Group for Emergencies, told BBC Radio 4's Today programme on Monday that in the absence of social distancing measures, which he did agree with, "we are reliant on immunity building up in the population".

He added: "That happens two ways – one through vaccination, and one through people getting infected and so the faster we can roll our additional vaccination, the better in terms of stopping people getting severely ill but also in reducing transmission."

He said the UK had been leading in Europe on vaccination until recently but other countries such as Spain, Portugal, France, Italy and Ireland "have got higher vaccination levels than us and that's largely because they have rolled out vaccination of 12 to 15-year-olds faster than us.

"They also vaccinated more recently, and we know now that vaccine effectiveness decays over time, we always expected that, and so they have more immunity in the population.

"They also principally used the Pfizer vaccine which against Delta is somewhat more effective than the AstraZeneca vaccine, so there are a set of countries in Europe with considerably more population immunity than us and I think if we want to stop the risk of the large autumn and winter wave we need to boost immunity in the population."

Ferguson said vaccinating teenagers with a first shot was the priority as the UK looks at dealing with any autumn and winter surges in Covid. But he said evidence from Israel suggested booster shots for a wider population were "very effective at further driving down transmission and infection".

Asked whether a further lockdown could be ruled out, he said "I hope so" but added that "you can't rule out anything completely".

The issue of vaccine passports has caused growing disquiet among Tory ranks, as well as facing opposition from opposition parties and industry figures.

The decision not to implement them means measures in England deviate from those in Scotland, where a motion on their introduction was passed in the Scottish Parliament on Thursday, while a decision is expected in Wales next week.

Stormont ministers have yet to reach an official position on using vaccine access passports within Northern Ireland.

By Jane Kirby and Sam Blewett

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.